WCRI Issues & Research Conference 2024

Event Details

Start: March 5, 2024 @ 8:00AM EST On-Demand End: March 6, 2024 @ EST On-Demand Location: The Westin Copley Place Hotel, Boston, MA 02116

The WCRI conference is a leading workers’ compensation forum. Their two-day program highlights the Institute’s latest research while drawing upon the diverse perspectives of highly respected workers’ compensation experts and policymakers from across the country.

Enlyte will be a sponsor at the inaugural WCRI Member-Only Reception at the Boston Public Library on Tuesday, March 5 from 5:30–7:00 pm. For more information, visit the WCRI Conference site.

More stories

Workers' Comp Case Study

Practical Application of Behavioral Coaching Techniques

April 2, 2025

This case study showcases the power of behavioral coaching techniques in transforming an injured employee’s recovery. Through empathy, active listening, and strategic intervention, Enlyte’s Telephonic Case Manager helped break barriers to healing—leading to improved outcomes, renewed engagement and meaningful cost savings.

Workers' Comp White Paper

From Setback to Comeback: Effective Solutions for Delayed Recovery

April 2, 2025

Learn how to effectively ignite workers' compensation recovery by addressing some of the biggest return-to-work obstacles, including mental health comorbidities, social factors, and delayed intervention. See how data-driven strategies lead to successful claims management and faster employee recovery.

Workers' Comp Podcast

Pulsing Recovery: Bone Growth Stimulation's Impact on Comp

April 2, 2025

Discover how bone growth stimulators are accelerating recovery in workers’ comp. Nicole Usher joins the Enlyte Envision podcast to discuss how BGS devices support healing in complex fractures and spinal surgeries.

Workers' Comp Article

Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain

April 1, 2025

The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.

Risk & Insurance In the News

The AI Balancing Act: Navigating Innovation in Workers’ Compensation

March 26, 2025

Industry expert Michael Cwynar of Enlyte discusses how to strike the right balance between AI innovation and professional expertise in today’s rapidly evolving tech landscape.

Workers' Comp Article

10 Ways Field Case Management Can Make a Difference

March 25, 2025

Enlyte's field case management provides empathetic, innovative support for injured employees, guiding recovery with tailored solutions. Discover how our comprehensive approach can enhance your workers' compensation outcomes.